Publications by authors named "Mary Beth Rodal"

Claim this Profile
P
Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.
Robert Wesolowski, Neelesh Sharma, Laura Reebel, Mary Beth Rodal, Alexandra Peck

Ther Adv Med Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer.
Balazs Halmos, Yuxia Jia, Joseph A Bokar, Pingfu Fu, David J Adelstein, Mary Beth Rodal

Invest New Drugs· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of pomalidomide given for patients with advanced solid tumors.
Matthew M Cooney, Charles Nock, Joseph Bokar, Smitha Krishnamurthi, Joseph Gibbons, Mary Beth Rodal

Cancer Chemother Pharmacol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis